Zeria Pharmaceutical Co., Ltd. (TYO:4559)
2,183.00
-23.00 (-1.04%)
Mar 10, 2025, 3:30 PM JST
Zeria Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 7, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Market Capitalization | 99,047 | 93,978 | 98,960 | 85,331 | 96,124 | 96,884 | Upgrade
|
Market Cap Growth | 21.07% | -5.03% | 15.97% | -11.23% | -0.78% | 3.75% | Upgrade
|
Enterprise Value | 118,840 | 125,376 | 134,397 | 126,409 | 124,464 | 126,509 | Upgrade
|
Last Close Price | 2247.00 | 2110.33 | 2178.75 | 1813.48 | 1968.83 | 1924.48 | Upgrade
|
PE Ratio | 13.15 | 12.16 | 15.97 | 21.54 | 30.82 | 33.12 | Upgrade
|
Forward PE | 10.06 | 11.34 | 12.53 | 20.60 | 28.59 | 26.91 | Upgrade
|
PS Ratio | 1.20 | 1.24 | 1.45 | 1.43 | 1.73 | 1.60 | Upgrade
|
PB Ratio | 1.16 | 1.18 | 1.51 | 1.55 | 1.71 | 1.84 | Upgrade
|
P/TBV Ratio | 2.42 | 2.58 | 4.21 | 6.23 | 6.89 | 4.28 | Upgrade
|
P/FCF Ratio | - | 10.12 | 9.20 | 10.82 | 15.60 | 14.62 | Upgrade
|
P/OCF Ratio | - | 7.71 | 7.52 | 9.53 | 13.94 | 13.36 | Upgrade
|
EV/Sales Ratio | 1.44 | 1.66 | 1.97 | 2.12 | 2.24 | 2.09 | Upgrade
|
EV/EBITDA Ratio | 6.36 | 7.30 | 8.86 | 10.74 | 15.80 | 15.91 | Upgrade
|
EV/EBIT Ratio | 11.81 | 13.03 | 14.91 | 19.86 | 36.15 | 31.56 | Upgrade
|
EV/FCF Ratio | - | 13.51 | 12.49 | 16.03 | 20.21 | 19.08 | Upgrade
|
Debt / Equity Ratio | 0.52 | 0.58 | 0.75 | 0.95 | 0.89 | 0.67 | Upgrade
|
Debt / EBITDA Ratio | 2.32 | 2.69 | 3.26 | 4.44 | 6.34 | 4.42 | Upgrade
|
Debt / FCF Ratio | - | 4.98 | 4.60 | 6.62 | 8.11 | 5.31 | Upgrade
|
Asset Turnover | 0.53 | 0.53 | 0.53 | 0.48 | 0.49 | 0.56 | Upgrade
|
Inventory Turnover | 1.47 | 1.48 | 1.53 | 1.51 | 1.53 | 1.70 | Upgrade
|
Quick Ratio | 0.87 | 0.76 | 0.71 | 0.63 | 0.43 | 0.54 | Upgrade
|
Current Ratio | 1.19 | 1.06 | 1.02 | 0.94 | 0.69 | 0.85 | Upgrade
|
Return on Equity (ROE) | 9.10% | 10.58% | 10.28% | 7.14% | 5.75% | 5.25% | Upgrade
|
Return on Assets (ROA) | 4.19% | 4.21% | 4.35% | 3.23% | 1.90% | 2.34% | Upgrade
|
Return on Capital (ROIC) | 5.01% | 4.99% | 5.07% | 3.73% | 2.22% | 2.74% | Upgrade
|
Return on Capital Employed (ROCE) | 10.41% | 10.02% | 10.26% | 7.95% | 5.06% | 6.35% | Upgrade
|
Earnings Yield | 7.61% | 8.23% | 6.26% | 4.64% | 3.24% | 3.02% | Upgrade
|
FCF Yield | 9.88% | 10.87% | 9.24% | 6.41% | 6.84% | Upgrade
| |
Dividend Yield | 2.10% | 2.08% | 1.84% | 1.93% | 1.73% | 1.77% | Upgrade
|
Payout Ratio | 0.00% | 25.03% | 25.67% | 38.83% | 50.27% | 54.60% | Upgrade
|
Buyback Yield / Dilution | 0.01% | 0.21% | 2.14% | 2.02% | 1.37% | 5.92% | Upgrade
|
Total Shareholder Return | 2.11% | 2.30% | 3.98% | 3.95% | 3.10% | 7.69% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.